• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic.

作者信息

Martin Ellen, Philbin Marie, Hughes Gerry, Bergin Colm, Talento Alida Fe

机构信息

Antimicrobial Resistance and Infection Control Division of HPSC, 25-27 Middle Gardiner Street, Dublin 1, Ireland.

Department of Infectious Diseases, St James's Hospital, James's Street, Dublin 8, Ireland.

出版信息

J Antimicrob Chemother. 2021 Jan 1;76(1):272-275. doi: 10.1093/jac/dkaa400.

DOI:10.1093/jac/dkaa400
PMID:33011763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7665520/
Abstract
摘要

相似文献

1
Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic.新冠疫情期间急症医院环境中的抗菌药物管理挑战与创新举措
J Antimicrob Chemother. 2021 Jan 1;76(1):272-275. doi: 10.1093/jac/dkaa400.
2
Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?2019年冠状病毒病疫情的附带损害：抗菌药物耐药性加剧及抗菌药物管理计划受到干扰？
S Afr Med J. 2020 Jun 2;110(7):572-573. doi: 10.7196/SAMJ.2020.v110i7.14917.
3
Could the COVID-19 pandemic aggravate antimicrobial resistance?新冠疫情会加剧抗菌药物耐药性吗？
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
4
Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.大流行中的抗菌药物管理：收拾残局。
Clin Infect Dis. 2021 May 18;72(10):e542-e544. doi: 10.1093/cid/ciaa1273.
5
COVID-19 will further exacerbate global antimicrobial resistance.新型冠状病毒肺炎将进一步加剧全球抗菌药物耐药性。
J Travel Med. 2020 Sep 26;27(6). doi: 10.1093/jtm/taaa098.
6
Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities.新冠疫情期间纽约市一家医院的抗菌药物管理视角：挑战与机遇。
Am J Health Syst Pharm. 2021 Mar 31;78(8):743-750. doi: 10.1093/ajhp/zxaa419.
7
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?冠状病毒病（COVID-19）会对抗菌素耐药性产生影响吗？
Euro Surveill. 2020 Nov;25(45). doi: 10.2807/1560-7917.ES.2020.25.45.2001886.
8
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
9
Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).抗菌药物管理计划：在全球 2019 冠状病毒病（COVID-19）大流行期间，医院的重要资源。
Int J Antimicrob Agents. 2020 Nov;56(5):106145. doi: 10.1016/j.ijantimicag.2020.106145. Epub 2020 Aug 27.
10
Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect?抗生素耐药性增强是新冠疫情的附带影响？
J Hosp Infect. 2021 Jan;107:114-115. doi: 10.1016/j.jhin.2020.11.010. Epub 2020 Nov 17.

引用本文的文献

1
Impact of COVID-19 on Antimicrobial Stewardship Activities in Hospitalised Children: A Scoping Review.新冠病毒病对住院儿童抗菌药物管理活动的影响：一项范围综述
J Paediatr Child Health. 2025 Mar;61(3):333-343. doi: 10.1111/jpc.16786. Epub 2025 Jan 22.
2
Antimicrobial prescribing practices and factors associated with antimicrobial prescribing in hospitalized COVID-19 patients in Oyo state: A retrospective study.奥约州住院COVID-19患者的抗菌药物处方实践及与抗菌药物处方相关的因素：一项回顾性研究。
PLOS Glob Public Health. 2024 Nov 13;4(11):e0003911. doi: 10.1371/journal.pgph.0003911. eCollection 2024.
3
Etiology and antimicrobial susceptibility patterns of bacteria causing pneumonia among adult patients with signs and symptoms of lower respiratory tract infections during the COVID-19 pandemic in Mwanza, Tanzania: a cross-sectional study.坦桑尼亚姆万扎地区2019冠状病毒病大流行期间有下呼吸道感染体征和症状的成年患者中引起肺炎的细菌的病因及抗菌药物敏感性模式：一项横断面研究
Pneumonia (Nathan). 2024 Sep 5;16(1):16. doi: 10.1186/s41479-024-00137-9.
4
Impacts of COVID-19 pandemic on culture-proven sepsis in neonates.COVID-19 大流行对培养证实的新生儿败血症的影响。
Front Cell Infect Microbiol. 2024 Jun 6;14:1391929. doi: 10.3389/fcimb.2024.1391929. eCollection 2024.
5
Uropathogens' Antibiotic Resistance Evolution in a Female Population: A Sequential Multi-Year Comparative Analysis.女性人群中尿路病原体的抗生素耐药性演变：一项多年序贯比较分析
Antibiotics (Basel). 2023 May 23;12(6):948. doi: 10.3390/antibiotics12060948.
6
Trends in antibiotic use before and during the coronavirus disease 2019 (COVID-19) pandemic across an integrated health system with different antimicrobial stewardship program models trends in antibiotic use by ASP model.2019年冠状病毒病（COVID-19）大流行之前及期间，不同抗菌药物管理项目模式的综合卫生系统中抗生素使用趋势：按抗菌药物管理项目模式划分的抗生素使用趋势
Antimicrob Steward Healthc Epidemiol. 2022 Apr 8;2(1):e55. doi: 10.1017/ash.2022.39. eCollection 2022.
7
Leveraging antimicrobial stewardship programs in response to the coronavirus disease 2019 (COVID-19) public health emergency.利用抗菌药物管理计划应对2019冠状病毒病（COVID-19）公共卫生紧急情况。
Antimicrob Steward Healthc Epidemiol. 2022 Mar 14;2(1):e41. doi: 10.1017/ash.2022.34. eCollection 2022.
8
The impact of COVID-19 on antimicrobial stewardship programme implementation in hospitals - an exploration informed by the Consolidated Framework for Implementation Research.COVID-19 对医院抗菌药物管理计划实施的影响 - 基于实施研究综合框架的探索。
J Hosp Infect. 2022 Nov;129:144-152. doi: 10.1016/j.jhin.2022.08.005. Epub 2022 Aug 23.
9
Beyond the Pandemic: The Value of Antimicrobial Stewardship.疫情之外：抗菌药物管理的价值
Front Public Health. 2022 Jun 27;10:902835. doi: 10.3389/fpubh.2022.902835. eCollection 2022.
10
The Collateral Effects of COVID-19 Pandemic on the Status of Carbapenemase-Producing Pathogens.**新冠疫情对产碳青霉烯酶病原体状况的附带影响**。
Front Cell Infect Microbiol. 2022 Mar 17;12:823626. doi: 10.3389/fcimb.2022.823626. eCollection 2022.

本文引用的文献

1
Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs.抗菌药物管理是新冠疫情应对工作的核心：对维持和建立相关项目的启示
Curr Infect Dis Rep. 2020;22(9):23. doi: 10.1007/s11908-020-00734-x. Epub 2020 Jul 3.
2
Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients.在电子病历中重新利用抗菌药物管理工具来管理 COVID-19 患者。
Infect Control Hosp Epidemiol. 2020 Nov;41(11):1335-1337. doi: 10.1017/ice.2020.281. Epub 2020 Jun 8.
3
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月，美国密歇根州底特律市，COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
4
COVID-19 and the potential long-term impact on antimicrobial resistance.COVID-19 与潜在的长期抗菌药物耐药性影响
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684. doi: 10.1093/jac/dkaa194.
5
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体：一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
6
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.2019年冠状病毒病（COVID-19）重症患者的降钙素原：一项荟萃分析。
Clin Chim Acta. 2020 Jun;505:190-191. doi: 10.1016/j.cca.2020.03.004. Epub 2020 Mar 4.